Dr. Priya Nandakumar brings scientific and clinical insight to The Catalyst Brief’s coverage of biomedical research and healthcare innovation. Her work bridges experimental findings, clinical data, and industry strategy, helping readers interpret what new evidence means beyond the lab or trial setting. At The Catalyst Brief, Priya emphasizes translational relevance and long-term implications for patients and pipelines.
160 articlesMostly Regulatory & Policy and Biopharmaceutical Industry
Medical TechnologyAs digital care continues to transform healthcare delivery, Maven Clinic’s research institute represents a strategic effort to assess and amplify the impact of such innovations. This analytic post explores the institute's mission, expected contributions, and potential implications for women’s and family health.
Dr. Priya NandakumarJan 30, 2026
Medical TechnologyThe dispute between Epic Systems and Health Gorilla goes beyond a single lawsuit, reflecting broader tensions within healthcare’s evolving digital landscape. This article examines the implications of this case for medical record control, data sharing protocols, and regulatory frameworks in healthcare IT.
Dr. Priya NandakumarJan 30, 2026
Medical TechnologyEarly cancer detection remains a critical challenge in oncology, with significant implications for patient outcomes and healthcare costs. Endeavor Health's investigation into blood-based multi-cancer detection tests represents a pivotal step towards wider clinical adoption of these emerging technologies.
Dr. Priya NandakumarJan 27, 2026
Healthcare InvestmentAs measles cases rise across the United States, the implications extend beyond public health, impacting hospital finances and the broader healthcare infrastructure. Stakeholders express concern over these intertwined challenges amid warnings from health officials about vaccine complacency and resource constraints.
Dr. Priya NandakumarJan 22, 2026